- Solana reclaimed the $233.8 level with a strong double-bottom bounce, forming a bullish setup that projects a potential rally toward $457.97.
- Institutions purchased over $28 million worth of Solana after the $233.8 level held, reinforcing accumulation strength and supporting a bullish continuation.
- Helius Medical Technologies adopted Solana as its primary treasury reserve, securing $500M funding with plans to expand holdings over 12–24 months.
Solana (SOL) has reclaimed and bounced from the critical $233.8 level, fueling expectations of an +82% rally toward the $457.97 target.
$233.8 Level Sparks Bullish Continuation
Market analyst Javon Marks described Solana’s recovery at $233.8 as a textbook bullish continuation signal. The level, once firm resistance, has now turned into solid support. This shift represents a key change in trader confidence.
The bounce created a clean double-bottom structure, strengthening the technical case for further gains. Such formations are often used by traders to confirm accumulation phases. Marks noted that the setup offers a clear stop level while opening the door to strong upside potential.
With Solana holding its broader uptrend, the technical projection of $457.97 reflects structured chart analysis. If momentum continues, the +82% advance would extend the current trend while validating $233.8 as a foundation level.
Institutional Buying Reinforces the Setup
Institutional activity has supported the bullish structure at $233.8. According to CryptoCurb, over $28 million in SOL was purchased by an institution just hours after the level held.
This buying activity strengthens the bounce by adding depth at the support zone. Institutions often enter when technical conditions align with long-term fundamentals, signaling confidence in sustained growth.
With accumulation concentrated near $233.8, the probability of Solana maintaining support increases. The reinforced level creates the platform from which the targeted $457.97 move could materialize.
Helius Treasury Adoption Aligns With Rally Prospects
Helius Medical Technologies further bolstered Solana’s bullish outlook with a $500 million funding round backed by Pantera Capital and Summer Capital. The company announced plans to adopt Solana as its primary treasury reserve asset.
By allocating reserves into SOL, Helius aligns corporate strategy with Solana’s technical strength. The bounce at $233.8 provides a favorable entry point, with long-term accumulation supporting the case for higher valuations.
Helius intends to expand its Solana holdings over the next 12–24 months, potentially scaling above $1.25 billion if warrants are exercised. This steady expansion mirrors institutional buying behavior and aligns with projections of Solana advancing toward $457.97.
